Abstract:ABSTRACT Staphylococcus aureus ( S. aureus ) is a leading cause of bacteremia and blood stream infections. Methicillin-resistant S. aureus (MRSA) that first appeared in 1961 often caused hospital-acquired infections (HAIs) and community-acquired infections (CAIs) and was associated with high mortality rate. Accurate and rapid point-of-care testing (POCT) of MRSA is crucial for clinical management and treatment of MRSA infections, as well as the prevention and control of HAIs and CAIs. Here, we reported a novel extraction-free dual HiFi-LAMP assay for discriminative detection of methicillin-susceptible S. aureus and MRSA. The dual HiFi-LAMP assay can detect 30 copies/reaction of nuc and mecA genes with detection limits of 147 and 158 copies per 25 μL reaction, respectively. A retrospective clinical evaluation with 107 clinical S. aureus isolates showed both sensitivity and specificity of 100%. A prospective clinical evaluation with 35 clinical samples revealed a specificity of 100% and a sensitivity of 92.3%. The dual HiFi-LAMP assay can detect almost all S. aureus samples (141/142; 99.3%) within 20 min, implying that the entire HiFi-LAMP assay (including sample process) can be completed within 40 min, extremely significantly shorter than 3–5 days by the traditional clinical microbial culture and antibiotic susceptibility testing. The novel extraction-free dual HiFi-LAMP assay can be used as a robust POCT tool to promote precise diagnosis and treatment of MRSA infections in hospitals and to facilitate surveillance of MRSA at hospital and community settings. IMPORTANCE Methicillin-resistant Staphylococcus aureus (MRSA) was associated with high mortality rate and listed as a “priority pathogen” by the World Health Organization. Accurate and rapid point-of-care testing (POCT) of MRSA is critically required for clinical management and treatment of MRSA infections. Some previous LAMP-based POCT assays for MRSA might be questionable due to their low specificity and the lack of appropriate evaluation directly using clinical samples. Furthermore, they are relatively tedious and time-consuming because they require DNA extraction and lack multiplex detection capacity. Here, we reported a novel extraction-free dual HiFi-LAMP assay for discriminative detection of MRSA and methicillin-susceptible S. aureus . The assay has high specificity and sensitivity and can be completed within 40 min. Clinical evaluation with real clinical samples and clinical isolates showed excellent performance with 100% specificity and 92.3%–100% sensitivity. The novel extraction-free assay may be a robust POCT tool to promote precise diagnosis of MRSA infections and facilitate surveillance of MRSA at hospital and community settings.

Development and application of a triplex‐PCR assay for rapid detection of methicillin‐resistant Staphylococcus aureus from pigs

Development of triplex assay for simultaneous detection of Escherichia coli, methicillin resistant and sensitive Staphylococcus aureus in raw pork samples of retail markets

Development and Application of a Novel Multiplex Polymerase Chain Reaction (PCR) Assay for Rapid Detection of Various Types of Staphylococci Strains

Development and application of triplex-PCR assay for detection of Streptococcus suis type 2

Retracted: A Multiplex Pcr Assay for the Rapid and Sensitive Detection of Methicillin-Resistant Staphylococcus Aureus and Simultaneous Discrimination of Staphylococcus Aureus from Coagulase-Negative Staphylococci (retracted Article. See Vol. 79, Pg. Iv, 2014)

Development and Application of a Multiplex PCR for Detection of Strepto-coccus Suis, Actinobacillus Pleuropneumoniae and Haemophilus Parasuis

Development of a Real-Time Recombinase-Aided Amplification Method to Rapidly Detect Methicillin-Resistant Staphylococcus aureus

New Real-Time PCR Assay for Rapid Detection of Methicillin- Resistant Staphylococcus aureus Directly from Specimens Containing a Mixture of Staphylococci

Comparison of Different Phenotypic Methods of Detection of Methicillin-Resistant Staphylococcus aureus with Polymerase Chain Reaction

Multiplex Digital PCR-Based Development and discussion of the Detection of Genetic Association Between Staphylococcus aureus and mecA

Pathogenic and Virulence Factor Detection on Viable but Non-culturable Methicillin-Resistant Staphylococcus aureus

Development of a Triplex PCR Assay for Detection of Porcine Circovirus Type 2, Pseudorabies Virus and Porcine Parvovirus

Establishment of a Multiplex PCR Assay for Detection of SS-2,APP and PM

Accurate Detection of Methicillin-Resistant Staphylococcus aureus in Mixtures by Use of Single-Bacterium Duplex Droplet Digital PCR

Triplex PCR Combined with Magnetic Separation Strategy for Rapid and Specific Detection of Methicillin-Resistant Staphylococcus Aureus in Hospital Samples

Novel Multiplex PCR Assay for Detection of Chlorhexidine-Quaternary Ammonium, Mupirocin, and Methicillin Resistance Genes, with Simultaneous Discrimination of Staphylococcus aureus from Coagulase-Negative Staphylococci

A novel extraction-free dual HiFi-LAMP assay for detection of methicillin-sensitive and methicillin-resistant Staphylococcus aureus

Development of A Multiplex Pcr Method for Detection of the Genes Encoding 16s Rrna, Coagulase, Methicillin Resistance and Enterotoxins in Staphylococcus Aureus

A multiplex Taqman PCR assay for MRSA detection from whole blood

Development of Multiplex Polymerase Chain Reaction Assay for Rapid Detection of Staphylococcus Aureus and Selected Antibiotic Resistance Genes in Bovine Mastitic Milk Samples.

Multiple Cross Displacement Amplification Coupled with Nanoparticles-Based Lateral Flow Biosensor for Detection of Staphylococcus Aureus and Identification of Methicillin-Resistant S. Aureus.